Skip to main content
. Author manuscript; available in PMC: 2020 Aug 20.
Published in final edited form as: Depress Anxiety. 2018 Sep 5;35(12):1168–1177. doi: 10.1002/da.22827

FIGURE 2.

FIGURE 2

Trajectories of normalized tyrosine serum levels for all individual cases with premenstrual dysphoric disorder (PMDD) and controls. Time point 1, gonadal suppression; Time point 2, 4 weeks progesterone add-back. Average trends are represented by the bold regression line, triangles represent lower and upper quartiles and shadings standard errors